Guru Ownership Trend
Guru Analysis for Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $38.39 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $4.19 M net inflow during the quarter.
Recent activity highlights Joel Greenblatt who increased their stake by 57.8%. Conversely, Diamond Hill Capital reduced exposure by 20.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Aurinia Pharmaceuticals Inc. (AUPH)
Major holders include Renaissance Technologies (RenTech) ($25.36 M), Cliff Asness ($7.68 M), Joel Greenblatt ($2.03 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.46 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.19 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited AUPH. The total reported sell value was $762,681.05.
Yes, 0 managers opened new positions in AUPH, and 3 increased their existing holdings. The total reported buy value was $4.95 M.
